We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| 1 | Technology | 15.87% |
| 2 | Financials | 14.89% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Allstate
ALL
$64B
| $28.2M | 0.07% |
259,203
-123,921
| -32% | -$12.9M |
|
252
Delta Air Lines
DAL
$55.8B
| $27.9M | 0.07% |
484,508
-110,579
| -19% | -$6.55M |
|
253
ResMed
RMD
$28.9B
| $27.9M | 0.07% |
206,359
-22,869
| -10% | -$3M |
|
|
CUB
254
DELISTED
Cubic Corporation
CUB
| $27.9M | 0.07% |
+396,055
| New | +$27.1M |
|
255
Kroger
KR
$35.8B
| $27.7M | 0.07% |
1,074,383
-581,671
| -35% | -$13.5M |
|
256
Morgan Stanley
MS
$341B
| $27.5M | 0.07% |
644,503
-60,039
| -9% | -$2.57M |
|
257
TE Connectivity
TEL
$59.2B
| $27.4M | 0.07% |
294,073
-30,245
| -9% | -$2.78M |
|
258
DuPont de Nemours
DD
$18.3B
| $27.2M | 0.07% |
303,902
-116,773
| -28% | -$10.3M |
|
259
Travelers Companies
TRV
$77.7B
| $27.2M | 0.07% |
182,538
-6,493
| -3% | -$965K |
|
260
Marathon Petroleum
MPC
$90.6B
| $27M | 0.07% |
443,813
-189,945
| -30% | -$10M |
|
261
WSFS Financial
WSFS
$4.14B
| $26.6M | 0.07% |
603,495
-208,297
| -26% | -$8.76M |
|
|
CCMP
262
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $26.6M | 0.07% |
188,408
-93,520
| -33% | -$11.5M |
|
|
STOR
263
DELISTED
STORE Capital Corporation
STOR
| $26.5M | 0.07% |
708,585
+223,623
| +46% | +$8.01M |
|
264
Cigna
CI
$74.2B
| $26.4M | 0.07% |
173,935
-5,763
| -3% | -$938K |
|
265
Emergent Biosolutions
EBS
$393M
| $26.4M | 0.07% |
504,843
-205,408
| -29% | -$9.57M |
|
266
Regions Financial
RF
$27.2B
| $26.4M | 0.07% |
1,666,766
-736,292
| -31% | -$11.1M |
|
267
CSX Corp
CSX
$93.7B
| $26.4M | 0.07% |
1,141,506
-2,282,832
| -67% | -$53.1M |
|
|
MGP
268
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $26.3M | 0.07% |
875,890
+548,431
| +167% | +$16.5M |
|
269
Ambev
ABEV
$46.8B
| $26.3M | 0.07% |
5,685,169
-1,729,800
| -23% | -$8.28M |
|
270
Kimberly-Clark
KMB
$35.8B
| $26.1M | 0.07% |
183,679
-4,630
| -2% | -$636K |
|
271
First Interstate BancSystem
FIBK
$3.81B
| $25.9M | 0.06% |
644,129
+27,298
| +4% | +$1.07M |
|
|
HPP
272
Hudson Pacific Properties
HPP
$859M
| $25.8M | 0.06% |
110,091
+35,777
| +48% | +$8.53M |
|
273
Sysco
SYY
$39.1B
| $25.6M | 0.06% |
322,816
-115,989
| -26% | -$8.51M |
|
274
Dorman Products
DORM
$4.23B
| $25.4M | 0.06% |
319,653
+19,511
| +7% | +$1.51M |
|
275
Mercury Systems
MRCY
$5.95B
| $25.1M | 0.06% |
309,654
-56,604
| -15% | -$4.47M |
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.